-       Report 
- October 2025
-  280 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- September 2024
-  150 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- November 2023
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- April 2023
-  90 Pages 
- Asia Pacific 
   From       €1342EUR$1,500USD£1,180GBP 
                     -       Book 
- July 2020
- North America 
                  The Immune Disorder market within the context of Allergy and Immunology is a broad field of medical research and treatment. It encompasses a wide range of conditions, including asthma, food allergies, eczema, hay fever, and anaphylaxis. It also includes autoimmune diseases such as lupus, rheumatoid arthritis, and multiple sclerosis. Allergy and Immunology specialists diagnose and treat these conditions, as well as provide preventive care and education.
The Immune Disorder market is a rapidly    growing field, with new treatments and therapies being developed to improve patient outcomes. Research is ongoing to better understand the underlying causes of these conditions and to develop new treatments.
Companies in the Immune Disorder market include Allergan, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are involved in the development and marketing of treatments for allergies and immunological disorders. Show Less   Read more